Trial Profile
Exploratory Study of Topical Norepinephrine in Post-Surgical Breast Cancer Patients Receiving Radiotherapy
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase I/II
Latest Information Update: 14 May 2014
Price :
$35
*
At a glance
- Drugs Norepinephrine (Primary)
- Indications Ductal carcinoma; Radiodermatitis
- Focus Adverse reactions
- Sponsors ProCertus BioPharm
- 14 May 2014 New trial record